Skip to content
Review Open access

Metastatic niche shaped by host factors influences disseminated cancer cell fate.

Sep 2026 · FEBS Letters · 0 citations · 72 references
Medicine

TL;DR

A framework in which metastasis is dynamically codetermined by tumor cell plasticity and host systemic state is described, contextualized by recent mechanistic insights into how lifestyle and physiological states rewire organ microenvironments to become either permissive or restrictive to metastatic colonization is described.

Abstract

Metastasis is responsible for the vast majority of cancer-related deaths, yet organ selectivity and the fate of disseminated cancer cells remain incompletely understood. While tumor-intrinsic programs have been extensively characterized, increasing evidence indicates that host-related extrinsic factors critically modulate the molecular and cellular landscape of metastatic niches. Aging, dietary habits, microbiome, physical activity, smoking, air pollution, and chronic stress may reshape systemic inflammation, immune surveillance, vascular permeability, stromal composition, extracellular matrix remodeling, and metabolic signaling in organs commonly targeted by metastasis, including bone, lung, liver, and brain. These host-dependent alterations influence disseminated cancer cell homing, extravasation, dormancy, and proliferative outgrowth by reprogramming tissue-resident and recruited cell populations, as well as niche-derived soluble and mechanical cues. In this review, we describe a framework in which metastasis is dynamically codetermined by tumor cell plasticity and host systemic state, contextualized by recent mechanistic insights into how lifestyle and physiological states rewire organ microenvironments to become either permissive or restrictive to metastatic colonization. Understanding these interactions may reveal actionable targets for metastasis prevention and highlight modifiable behaviors as biological determinants of organ susceptibility to metastatic disease.

Read PDF

Similar papers

Review Aug 2026

Transforming Cancer Treatment: Integrative Strategies Targeting the Tumor Microenvironment through Biological Innovation and Artificial Intelligence.

This review comprehensively examines the cellular and acellular architecture of the TME, emphasizing its spatial organization, metabolic reprogramming, mechanical properties, and immunological regulation across diverse tumor types.

R. Latif, Taufiq Nawaz · 0 citations
Review 2026

Tumor-associated macrophages: Ontogeny, plasticity, spatial ecosystems, and therapeutic targeting.

This chapter provides an integrated framework for understanding TAM biology across multiple regulatory dimensions, including ontogeny, plasticity, metabolism, epigenetic control, and spatial niche organization, and synthesizes current and emerging therapeutic strategies targeting TAM recruitment, survival, reprogrammin...

Atif Elnaggar, Abdelrahman Elnaggar · 0 citations
Review Open access Oct 2026

Cancer Cell Metastasis: From Molecular Mechanisms to Therapeutic Strategies

ABSTRACT Cancer metastasis is a spatiotemporal dynamic process jointly driven by the intrinsic evolution of cancer cells and continuous microenvironmental selection, rather than a simple linear accumulation of genetic alterations. The metastatic diversity of cancers is driven by heterogeneity in physicochemical propert...

Yu-Peng Zhao, Wen-Chao Xu, Yi-Bo Wang et al. · 0 citations
Open access Sep 2026

An FEV-Associated Metastasis-Initiating-Like State Linked to Tumor Cell Plasticity and Immune Niche Remodeling in Prostate Cancer

Prostate cancer progression is accompanied by dynamic remodeling of malignant cell states, whose metastatic potential and regulatory programs remain poorly defined. Here, we integrated single-cell, spatial, bulk transcriptomic, epigenomic, and experimental data to characterize malignant cell state transitions and ident...

Si-Jia Wu, Jiang-Peng Wei, Xiao-Rui Shi et al. · 0 citations
Review Open access Sep 2026

Stemness plasticity in hepatocellular carcinoma: spatial niches and therapeutic implications.

Hepatocellular carcinoma (HCC) remains a major global health burden, with therapeutic resistance limiting the long-term efficacy of current treatments. Although cancer stem cell (CSC) models have been proposed to explain tumor initiation and relapse, strategies targeting marker-defined CSC populations have shown limite...

H. Ahn, Sujin Kim, H. Cho · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.